Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5326PDF: 2653HTML: 49582 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3625PDF: 1111HTML: 23339 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1884PDF: 700HTML: 237 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1479PDF: 781Suppl. Files: 327Html: 136 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1398PDF: 878HTML: 7956Untitled: 200 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1676PDF: 726HTML: 233 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3247PDF: 919HTML: 762text and figure: 229 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1596PDF: 939HTML: 4101Letter: 173 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1693PDF: 545HTML: 209 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7860PDF: 725HTML: 220 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3702PDF: 1240HTML: 3902Untitled: 216Untitled: 262 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2892PDF: 1366HTML: 3571Untitled: 194Untitled: 207Untitled: 180 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4855PDF: 1904HTML: 11148Fig 1: 224Fig 2: 185Fig 3: 302Fig 4: 189Fig 5: 182Fig 6: 177Fig 7: 193Fig 8: 184 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1739PDF: 1172HTML: 249 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3302PDF: 1115HTML: 447 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1605PDF: 803HTML: 1237Figure 1: 174Figure 2: 191Figure 3: 186 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2074PDF: 1049HTML: 15655COVER LETTER: 191 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2891PDF: 1102HTML: 3034 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4330PDF: 1379HTML: 2046 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
889PDF: 687HTML: 323 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7997PDF: 4178HTML: 7476 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
30PDF: 16HTML: 1







